Common prostate cancer treatment associated with decreased survival in older men
DETROIT - A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
DETROIT - A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at…
2009 study posted for filing Contact: Lori J. Shanks ljshanks@partners.org 617-534-1604 JAMA and Archives Journals Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy…
2009 study posted for filing Contact: Kristen Woodward kwoodwar@fhcrc.org 206-667-5095 Fred Hutchinson Cancer Research Center Study finds a more than four-fold increased risk of ER negative second cancers SEATTLE –…
Public release date: 12-Jan-2009 - They found women who had taken estrogen with or without progestin had smaller brain volumes - Brain volume was 2.37 cubic centimeters lower in the…
Public release date: 25-Nov-2008 ANN ARBOR, Mich.—Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new…
Public release date: 28-Apr-2008 Postmenopausal women taking hormone therapy appear to have an increased risk of stroke regardless of when they started treatment, according to a report in the April…
Public release date: 28-Oct-2007 Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential…
Public release date: 18-Sep-2007 STANFORD, Calif. - Despite the huge publicity generated by a 2002 study on the potential dangers of hormone therapy for postmenopausal women, new research from…
You must be logged in to post a comment.